Randomized, open-label, phase II trial of dostarlimab (TSR-042), as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemo-radiation: ATOMICC study

Autores: Oaknin, A.; Iglesias, M. ; Alarcon, J. D. ; Javierre, G. V.; Garcia, L. G.; Santaballa, A. ; Manso, L. M.; Romero, I. ; Ginesta, M. P. B. ; Churruca, C.; Garcia, Y. ; Sanchez, A. B.; Marquina, G.; Pardo, B.; Redondo, A. ; Rubio, M. J. ; González Martín, Antonio